Skip to main content
iNtRON Biotechnology, Inc. logo

iNtRON Biotechnology, Inc. — Investor Relations & Filings

Ticker · 048530 ISIN · KR7048530000 KO Manufacturing
Filings indexed 268 across all filing types
Latest filing 2020-08-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 048530

About iNtRON Biotechnology, Inc.

https://intronbio.com:6001

iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Intron Biotechnology regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2020-08-28 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This type of filing specifically details the company's decision to buy back its own shares through a trust, which falls under the category of 'Transaction in Own Shares'.
2020-08-28 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '인트론바이오테크놀로지' (iNtRON Biotechnology) for the period ending June 30, 2020. It contains detailed financial information, business descriptions, capital structure, and management discussions, which are characteristic of an interim financial report. It is not a mere announcement or certification, but the full report itself. H1 2020
2020-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Intron Biotechnology for the second quarter of 2020. It provides key financial highlights such as revenue, operating profit, and net income, comparing them to previous periods. This is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). H1 2020
2020-08-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule report). It details the share ownership, changes in holdings, and the purpose of investment by Mirae Asset Global Investments in Intron Biotechnology. This falls under the category of 'Major Shareholding Notification' as it tracks significant ownership thresholds.
2020-07-01 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This document details the company's decision to buy back its own shares through a trust, which falls under the category of 'Transaction in Own Shares'.
2020-06-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.